Precautions for indicating non-steroidal anti-inflammatory to control dental pain in patients with COVID-19
Keywords:
biosegurídad, odontología, dental, epidemiología, infectologíaDownloads
References
Basille D, Plouvier N, Trouve C, Duhaut P, Andrejak C, Jounieaux V. Non-steroidal Anti-inflammatory Drugs may Worsen the Course of Community-Acquired Pneumonia: A Cohort Study. Lung. 2017;195(2):201-208. doi:10.1007/s00408-016-9973-1
Sodhi M, Khosrow-Khavar F, FitzGerald JM, Etminan M. Non-steroidal Anti-inflammatory Drugs and the Risk of Pneumonia Complications: A Systematic Review [published online ahead of print, 2020 Jul 26]. Pharmacotherapy. 2020;10.1002/phar.2451. doi:10.1002/phar.2451. Disponible en: https://accpjournals.onlinelibrary.wiley.com/doi/full/10.1002/phar.2451
Russell B, Moss C, Rigg A, Van Hemelrijck M. COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?. Ecancermedicalscience. 2020;14:1023. Published 2020 Mar 30. doi:10.3332/ecancer.2020.1023. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105332/
FitzGerald GA. Misguided drug advice for COVID-19. Science. 2020;367(6485):1434. doi:10.1126/science.abb8034. Disponible en: https://science.sciencemag.org/content/367/6485/1434.1.long
Bruce E, Barlow-Pay F, Short R, Vilches-Moraga A, Angeline Price A, McGovern A, et al. Prior Routine Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Important Outcomes in Hospitalised Patients with COVID-19. J Clin Med. 2020;9(8):E2586. Published 2020 Aug 10. doi:10.3390/jcm9082586. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC746519/
Published
How to Cite
Issue
Section
License
Authors retain all rights to their works, which they can reproduce and distribute as long as they cite the primary source of publication.
The Rev Cubana Estomatol is subject to the Creative Commons Attribution-Non-Commercial 4.0 International License (CC BY-NC 4.0) and follows the publication model of SciELO Publishing Schema (SciELO PS) for publication in XML format.
You are free to:
- Share — copy and redistribute the material in any medium or format.
- Adapt — remix, transform, and build upon the material.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
- You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
- No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
Download PDF
